PAI-1 Level Differences in Malignant Plural Effusion, Parapneumonic Pleuritis, and Cardiac Hydrothorax
<i>Background and Objectives:</i> Plasminogen activator inhibitor-1 (PAI-1) is a fibrinolytic system enzyme whose role in various fibrinolytic processes is currently unknown. In clinical manifestations of pleural liquids of diverse etiology, various levels of fibrinolytic activity can be...
Main Authors: | Dace Zentina, Inga Stukena, Alvils Krams, Aivars Lejnieks |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1010-660X/55/9/567 |
Similar Items
-
Diagnostic value of tumour markers Ca-125 and CEA in the diagnostics of malignant pleural fluids
by: Žentiņa Dace, et al.
Published: (2016-04-01) -
Diagnostic value of calprotectin in differentiation between benign and malignant pleural effusion
by: Omar M. Mohammed, et al.
Published: (2019-07-01) -
Diagnostic role of interleukin -33 in the differentiation of pleural effusions especially tuberculous and malignant effusions
by: Abdel-sadek Hamed Al-aarag, et al.
Published: (2019-06-01) -
Evaluation of pleural fluid YKL-40 as a marker of malignant pleural effusion
by: Adel Attia, et al.
Published: (2015-04-01) -
Transudative Effusion of Malignant Etiology: An Interesting Case Report
by: Swathi Karanth M. P, et al.
Published: (2018-01-01)